EA201390293A1 - Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности - Google Patents
Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточностиInfo
- Publication number
- EA201390293A1 EA201390293A1 EA201390293A EA201390293A EA201390293A1 EA 201390293 A1 EA201390293 A1 EA 201390293A1 EA 201390293 A EA201390293 A EA 201390293A EA 201390293 A EA201390293 A EA 201390293A EA 201390293 A1 EA201390293 A1 EA 201390293A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- peptide
- compositions
- keratin
- methods
- kidney damage
- Prior art date
Links
- 230000006378 damage Effects 0.000 title abstract 2
- 210000003734 kidney Anatomy 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000001647 Renal Insufficiency Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 201000006370 kidney failure Diseases 0.000 title 1
- 102000005706 Keratin-6 Human genes 0.000 abstract 2
- 108010070557 Keratin-6 Proteins 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- 210000004292 cytoskeleton Anatomy 0.000 abstract 2
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 abstract 1
- 102000054930 Agouti-Related Human genes 0.000 abstract 1
- 101710127426 Agouti-related protein Proteins 0.000 abstract 1
- 101710111255 Appetite-regulating hormone Proteins 0.000 abstract 1
- 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 abstract 1
- 102100031614 Ciliary neurotrophic factor Human genes 0.000 abstract 1
- 102100027995 Collagenase 3 Human genes 0.000 abstract 1
- 102000016550 Complement Factor H Human genes 0.000 abstract 1
- 108010053085 Complement Factor H Proteins 0.000 abstract 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 abstract 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 abstract 1
- 102000016970 Follistatin Human genes 0.000 abstract 1
- 108010014612 Follistatin Proteins 0.000 abstract 1
- 108010004460 Gastric Inhibitory Polypeptide Proteins 0.000 abstract 1
- 102100039994 Gastric inhibitory polypeptide Human genes 0.000 abstract 1
- 102000012004 Ghrelin Human genes 0.000 abstract 1
- 102000051325 Glucagon Human genes 0.000 abstract 1
- 108060003199 Glucagon Proteins 0.000 abstract 1
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 abstract 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract 1
- 108010034219 Insulin Receptor Substrate Proteins Proteins 0.000 abstract 1
- 102000009433 Insulin Receptor Substrate Proteins Human genes 0.000 abstract 1
- 102000013691 Interleukin-17 Human genes 0.000 abstract 1
- 108050003558 Interleukin-17 Proteins 0.000 abstract 1
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 abstract 1
- 108010041872 Islet Amyloid Polypeptide Proteins 0.000 abstract 1
- 102100023970 Keratin, type I cytoskeletal 10 Human genes 0.000 abstract 1
- 102100022905 Keratin, type II cytoskeletal 1 Human genes 0.000 abstract 1
- 108010070514 Keratin-1 Proteins 0.000 abstract 1
- 108010065038 Keratin-10 Proteins 0.000 abstract 1
- 108010076503 Matrix Metalloproteinase 13 Proteins 0.000 abstract 1
- 102000003945 NF-kappa B Human genes 0.000 abstract 1
- 108010057466 NF-kappa B Proteins 0.000 abstract 1
- 108010025020 Nerve Growth Factor Proteins 0.000 abstract 1
- 102000015336 Nerve Growth Factor Human genes 0.000 abstract 1
- 102000004067 Osteocalcin Human genes 0.000 abstract 1
- 108090000573 Osteocalcin Proteins 0.000 abstract 1
- 108010071690 Prealbumin Proteins 0.000 abstract 1
- 102100040918 Pro-glucagon Human genes 0.000 abstract 1
- 206010061481 Renal injury Diseases 0.000 abstract 1
- 102000009190 Transthyretin Human genes 0.000 abstract 1
- 102000050760 Vitamin D-binding protein Human genes 0.000 abstract 1
- 101710179590 Vitamin D-binding protein Proteins 0.000 abstract 1
- 239000000090 biomarker Substances 0.000 abstract 1
- 239000000104 diagnostic biomarker Substances 0.000 abstract 1
- 239000002158 endotoxin Substances 0.000 abstract 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 abstract 1
- 229960004666 glucagon Drugs 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 102000007236 involucrin Human genes 0.000 abstract 1
- 108010033564 involucrin Proteins 0.000 abstract 1
- 208000037806 kidney injury Diseases 0.000 abstract 1
- 229920006008 lipopolysaccharide Polymers 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 229940053128 nerve growth factor Drugs 0.000 abstract 1
- 210000000496 pancreas Anatomy 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 239000000092 prognostic biomarker Substances 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39099910P | 2010-10-07 | 2010-10-07 | |
| PCT/US2011/055055 WO2012048082A2 (en) | 2010-10-07 | 2011-10-06 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201390293A1 true EA201390293A1 (ru) | 2013-09-30 |
Family
ID=45928428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201390293A EA201390293A1 (ru) | 2010-10-07 | 2011-10-06 | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20130316370A1 (https=) |
| EP (2) | EP3249402A1 (https=) |
| JP (3) | JP2013539861A (https=) |
| CN (1) | CN103238068B (https=) |
| AU (1) | AU2011311997A1 (https=) |
| CA (1) | CA2811438A1 (https=) |
| EA (1) | EA201390293A1 (https=) |
| IN (1) | IN2013MN00441A (https=) |
| MX (1) | MX2013003662A (https=) |
| NZ (1) | NZ608316A (https=) |
| WO (1) | WO2012048082A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3047270A4 (en) * | 2013-09-20 | 2017-07-19 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain |
| CA2939366A1 (en) * | 2014-02-20 | 2015-08-27 | Immundiagnostik Ag | In vitro diagnostic and prognosis of contrast induced nephropathy (cin) in patients undergoing coronary angiography |
| CN107709993A (zh) * | 2015-06-11 | 2018-02-16 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断和预后的方法和组合物 |
| CN106405064B (zh) * | 2016-08-30 | 2018-10-26 | 嘉兴行健生物科技有限公司 | 一种40岁以上女性骨转换率的评估方法 |
| JP7030834B2 (ja) * | 2017-03-16 | 2022-03-07 | 深▲セン▼先進技術研究院 | エネルギー代謝を調節するポリペプチド及びその使用 |
| CN109468357A (zh) * | 2018-12-25 | 2019-03-15 | 河北肽都生物科技有限公司 | 一种脾氨肽的制备方法 |
| JP7424593B2 (ja) * | 2019-07-26 | 2024-01-30 | フンダシオ・インスティトゥート・ディンヴェスティガシオ・ビオメディカ・デ・ベルヴィッチ（イディベル） | エルゴチオネイン、ｓ－メチル－エルゴチオネイン、及びそれらの使用 |
| CN113092768A (zh) * | 2019-12-23 | 2021-07-09 | 首都医科大学附属北京世纪坛医院 | 尿液角蛋白,ii型细胞骨架1及其多肽片段在过敏性疾病中的应用 |
| JP6895148B1 (ja) * | 2020-03-31 | 2021-06-30 | クラシエホールディングス株式会社 | 冷え保有者における冷えの原因が、腎機能低下、水分代謝異常又は副腎疲労にあることを判定する判定用マーカー、冷え保有者における冷えの原因が、腎機能低下、水分代謝異常又は副腎疲労にあることを判定する判定方法、及び冷え保有者における冷えの原因が、腎機能低下、水分代謝異常又は副腎疲労にあることを判定するための判定用キット |
| CN113777304A (zh) * | 2020-06-09 | 2021-12-10 | 张曼 | 尿液纤维蛋白溶解酶原及其多肽片段在烧伤中的应用 |
| CN114264828B (zh) * | 2022-01-28 | 2023-09-08 | 中国科学院基础医学与肿瘤研究所(筹) | 鉴别良性甲状腺结节与甲状腺癌的生物标志物及其应用 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| CA2072758A1 (en) | 1990-09-14 | 1992-03-15 | Kenneth Francis Buechler | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| CA2107894C (en) | 1991-04-10 | 2003-10-14 | Kenneth F. Buechler | Crosstalk inhibitors and their uses |
| EP0579767B1 (en) | 1991-04-11 | 2000-08-23 | Biosite Diagnostics Inc. | Novel conjugates and assays for simultaneous detection of multiple ligands |
| US6019944A (en) | 1992-05-21 | 2000-02-01 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| JP4487376B2 (ja) * | 2000-03-31 | 2010-06-23 | 味の素株式会社 | 腎疾患治療剤 |
| JP2002191398A (ja) * | 2000-12-26 | 2002-07-09 | Jenokkusu Soyaku Kenkyusho:Kk | アレルギー性疾患検査方法 |
| US20040253637A1 (en) * | 2001-04-13 | 2004-12-16 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| US20030224386A1 (en) * | 2001-12-19 | 2003-12-04 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis |
| WO2005000194A2 (en) * | 2002-10-08 | 2005-01-06 | Rinat Neuroscience Corp. | Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same |
| US6941172B2 (en) * | 2002-11-18 | 2005-09-06 | Zvi Nachum | Method and device for restoring kidney function using electromagnetic stimulation |
| WO2005100593A1 (en) * | 2004-04-16 | 2005-10-27 | Monash University | A method for monitoring the progress of cancer |
| US20050272101A1 (en) * | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
| FR2872579B1 (fr) * | 2004-06-30 | 2006-11-24 | Pasteur Institut | Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha |
| DE602005023216D1 (de) * | 2004-12-15 | 2010-10-07 | Beth Israel Hospital | Nukleinsäuren und polypeptide zur diagnose und behandlung von schwangerschaftskomplikationen |
| ES2818028T3 (es) * | 2004-12-20 | 2021-04-09 | Antibodyshop As | Determinación de lipocalina asociada a gelatinasa de neutrófilos (NGAL) como marcador diagnóstico para trastornos renales |
| US20070087387A1 (en) * | 2005-04-21 | 2007-04-19 | Prasad Devarajan | Method for the Early Detection of Renal Disease Using Proteomics |
| JP2007057509A (ja) * | 2005-08-26 | 2007-03-08 | Toray Ind Inc | ネコアクチビンａの測定方法およびその測定キット |
| WO2007106781A2 (en) * | 2006-03-10 | 2007-09-20 | University Of Rochester | Ecg-based differentiation of lqt1 and lqt2 mutation |
| EP2005187A4 (en) * | 2006-03-23 | 2010-04-21 | Life Technologies Corp | METHOD AND REAGENTS FOR IN VIVO IMAGING CANCER CELL LINES |
| US7662578B2 (en) * | 2006-04-21 | 2010-02-16 | Children's Hospital Medical Center | Method and kit for the early detection of impaired renal status |
| US20090047694A1 (en) * | 2007-08-17 | 2009-02-19 | Shuber Anthony P | Clinical Intervention Directed Diagnostic Methods |
| CN103399155A (zh) * | 2007-03-26 | 2013-11-20 | 诺瓦提斯公司 | 用于监测肾功能的预测性的肾安全性生物标志物和生物标志物标签 |
| WO2008150488A1 (en) * | 2007-06-01 | 2008-12-11 | Laboratory Corporation Of America Holdings | Methods and systems for quantification of peptides and other analytes |
| EP2203743A4 (en) * | 2007-09-20 | 2011-03-02 | Univ Louisville Res Found | PEPTIDE BIOMARKER FOR PREDICTING WEARNING OF THE KIDNEY FUNCTION AND A CHILDNESS |
| US7977110B2 (en) * | 2008-06-02 | 2011-07-12 | Children's Hospital Medical Center | Method for distinguishing between kidney dysfunctions |
| US20110287964A1 (en) * | 2008-11-17 | 2011-11-24 | The Brigham And Women's Hospital, Inc. | Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans |
| MX2011005379A (es) * | 2008-11-22 | 2011-06-09 | Astute Medical Inc | Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. |
| EP2394166B1 (en) * | 2009-02-06 | 2016-07-13 | Astute Medical, Inc. | Methods for diagnosis and prognosis of renal injury and failure |
| EP2393934A4 (en) * | 2009-02-06 | 2012-08-29 | Astute Medical Inc | DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE |
| EP3070474A3 (en) * | 2010-02-26 | 2016-12-07 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
-
2011
- 2011-10-06 CA CA2811438A patent/CA2811438A1/en not_active Abandoned
- 2011-10-06 EP EP17175396.5A patent/EP3249402A1/en not_active Withdrawn
- 2011-10-06 JP JP2013532937A patent/JP2013539861A/ja active Pending
- 2011-10-06 MX MX2013003662A patent/MX2013003662A/es not_active Application Discontinuation
- 2011-10-06 EA EA201390293A patent/EA201390293A1/ru unknown
- 2011-10-06 WO PCT/US2011/055055 patent/WO2012048082A2/en not_active Ceased
- 2011-10-06 US US13/878,124 patent/US20130316370A1/en not_active Abandoned
- 2011-10-06 AU AU2011311997A patent/AU2011311997A1/en not_active Abandoned
- 2011-10-06 IN IN441MUN2013 patent/IN2013MN00441A/en unknown
- 2011-10-06 EP EP11831575.3A patent/EP2625524A4/en not_active Withdrawn
- 2011-10-06 CN CN201180050168.8A patent/CN103238068B/zh not_active Expired - Fee Related
- 2011-10-06 NZ NZ60831611A patent/NZ608316A/en not_active IP Right Cessation
-
2016
- 2016-06-15 JP JP2016118970A patent/JP6321080B2/ja active Active
-
2018
- 2018-04-04 JP JP2018072166A patent/JP2018141793A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013539861A (ja) | 2013-10-28 |
| AU2011311997A1 (en) | 2013-04-04 |
| JP2018141793A (ja) | 2018-09-13 |
| CN103238068A (zh) | 2013-08-07 |
| IN2013MN00441A (https=) | 2015-05-29 |
| CN103238068B (zh) | 2016-06-08 |
| EP2625524A2 (en) | 2013-08-14 |
| WO2012048082A3 (en) | 2012-06-21 |
| NZ608316A (en) | 2015-03-27 |
| EP3249402A1 (en) | 2017-11-29 |
| JP2016180762A (ja) | 2016-10-13 |
| WO2012048082A2 (en) | 2012-04-12 |
| MX2013003662A (es) | 2013-05-01 |
| HK1186248A1 (zh) | 2014-03-07 |
| US20130316370A1 (en) | 2013-11-28 |
| EP2625524A4 (en) | 2014-05-07 |
| CA2811438A1 (en) | 2012-04-12 |
| JP6321080B2 (ja) | 2018-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201390293A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| Rost et al. | Brain natriuretic peptide predicts functional outcome in ischemic stroke | |
| WO2008060607A3 (en) | Methods and compositions for monitoring and risk prediction in cardiorenal syndrome | |
| Pulvirenti et al. | Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors | |
| ES2506116T3 (es) | Nuevo biomarcador para diagnóstico, predicción y/o pronóstico de septicemia y usos del mismo | |
| Yu et al. | Serum adropin levels are decreased in patients with acute myocardial infarction | |
| Schanstra et al. | Diagnosis and prediction of CKD progression by assessment of urinary peptides | |
| Fiorentino et al. | Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies | |
| Januzzi Jr et al. | IGFBP7 (insulin-like growth factor–binding protein-7) and neprilysin inhibition in patients with heart failure | |
| Nadim et al. | Simultaneous liver–kidney transplantation summit: current state and future directions | |
| Lattanzio et al. | Circulating dickkopf‐1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low‐dose aspirin | |
| Miller et al. | Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure | |
| Koh et al. | Recent update on acute kidney injury-to-chronic kidney disease transition | |
| Zhang et al. | Plasma copeptin and long‐term outcomes in acute ischemic stroke | |
| EA201290711A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| DK2491401T3 (en) | MCAM as a biomarker for fluid homeostasis | |
| WO2009101059A3 (en) | Methods of using cadherin 11 (cdh11) antagonists | |
| Bayes-Genis et al. | Multimarker testing with ST2 in chronic heart failure | |
| Gopal et al. | New and emerging biomarkers in left ventricular systolic dysfunction—insight into dilated cardiomyopathy | |
| EA201290629A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| NZ600828A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| GB0510511D0 (en) | Diagnosis of tuberculosis | |
| WO2008061149A3 (en) | Methods and compositions for diagnosis and prognosis of renal artery stenosis | |
| Wasilewska et al. | Markers of systemic inflammation in children with hyperuricemia | |
| Landman et al. | Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27) |